Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Estelle

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
The World Allergy Organization Journal|December 27, 2012
World allergy organization guidelines for the assessment and management of anaphylaxisF Estelle R Simons, Ledit R F Ardusso, M Beatrice Bilò, et al.
The World Allergy Organization Journal|November 4, 2015
2015 update of the evidence base: World Allergy Organization anaphylaxis guidelinesF Estelle R Simons, Motohiro Ebisawa, Mario Sanchez-Borges, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2009
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyTmirah Haselkorn, James E Fish, Robert S Zeiger, et al.
International Archives of Allergy and Immunology|September 7, 2013
World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence baseF Estelle R Simons, Ledit R F Ardusso, Vesselin Dimov, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 11, 2018
Critical view of anaphylaxis epidemiology: open questions and new perspectivesLuciana Kase Tanno, Ana Luiza Bierrenbach, F Estelle R Simons, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2012
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyBradley E Chipps, Robert S Zeiger, Larry Borish, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2003
Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitisUlrich Wahn, Eli O Meltzer, Albert F Finn, et al.
The Journal of Allergy and Clinical Immunology|May 14, 2003
First do no harm: managing antihistamine impairment in patients with allergic rhinitisThomas B Casale, Michael S Blaiss, Erwin Gelfand, et al.
Allergy|March 26, 2003
Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA)Jean Bousquet, Paul Van Cauwenberge, Claus Bachert, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
The World Allergy Organization Journal|December 27, 2012
World allergy organization guidelines for the assessment and management of anaphylaxisF Estelle R Simons, Ledit R F Ardusso, M Beatrice Bilò, et al.
The World Allergy Organization Journal|November 4, 2015
2015 update of the evidence base: World Allergy Organization anaphylaxis guidelinesF Estelle R Simons, Motohiro Ebisawa, Mario Sanchez-Borges, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2009
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyTmirah Haselkorn, James E Fish, Robert S Zeiger, et al.
International Archives of Allergy and Immunology|September 7, 2013
World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence baseF Estelle R Simons, Ledit R F Ardusso, Vesselin Dimov, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|April 11, 2018
Critical view of anaphylaxis epidemiology: open questions and new perspectivesLuciana Kase Tanno, Ana Luiza Bierrenbach, F Estelle R Simons, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2012
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) studyBradley E Chipps, Robert S Zeiger, Larry Borish, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2003
Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitisUlrich Wahn, Eli O Meltzer, Albert F Finn, et al.
The Journal of Allergy and Clinical Immunology|May 14, 2003
First do no harm: managing antihistamine impairment in patients with allergic rhinitisThomas B Casale, Michael S Blaiss, Erwin Gelfand, et al.
Allergy|March 26, 2003
Requirements for medications commonly used in the treatment of allergic rhinitis. European Academy of Allergy and Clinical Immunology (EAACI), Allergic Rhinitis and its Impact on Asthma (ARIA)Jean Bousquet, Paul Van Cauwenberge, Claus Bachert, et al.
Pageof 17